Limiting homologous recombination at stalled replication forks is essential for cell viability: DNA2 to the rescue.


Journal

Current genetics
ISSN: 1432-0983
Titre abrégé: Curr Genet
Pays: United States
ID NLM: 8004904

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 21 08 2020
accepted: 01 09 2020
revised: 27 08 2020
pubmed: 11 9 2020
medline: 1 6 2021
entrez: 10 9 2020
Statut: ppublish

Résumé

The disease-associated nuclease-helicase DNA2 has been implicated in DNA end-resection during DNA double-strand break repair, Okazaki fragment processing, and the recovery of stalled DNA replication forks (RFs). Its role in Okazaki fragment processing has been proposed to explain why DNA2 is indispensable for cell survival across organisms. Unexpectedly, we found that DNA2 has an essential role in suppressing homologous recombination (HR)-dependent replication restart at stalled RFs. In the absence of DNA2-mediated RF recovery, excessive HR-restart of stalled RFs results in toxic levels of abortive recombination intermediates that lead to DNA damage-checkpoint activation and terminal cell-cycle arrest. While HR proteins protect and restart stalled RFs to promote faithful genome replication, these findings show how HR-dependent replication restart is actively constrained by DNA2 to ensure cell survival. These new insights disambiguate the effects of DNA2 dysfunction on cell survival, and provide a framework to rationalize the association of DNA2 with cancer and the primordial dwarfism disorder Seckel syndrome based on its role in RF recovery.

Identifiants

pubmed: 32909097
doi: 10.1007/s00294-020-01106-7
pii: 10.1007/s00294-020-01106-7
pmc: PMC7599155
doi:

Substances chimiques

Okazaki fragments 0
DNA 9007-49-2
DNA Helicases EC 3.6.4.-
DNA2 protein, human EC 3.6.4.12

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1085-1092

Références

EMBO Rep. 2020 Jul 3;21(7):e49367
pubmed: 32419301
J Cell Biol. 2019 Apr 1;218(4):1096-1107
pubmed: 30670471
Nature. 2010 Sep 2;467(7311):112-6
pubmed: 20811461
Science. 2008 Oct 24;322(5901):597-602
pubmed: 18948542
Cell. 2012 Jun 8;149(6):1221-32
pubmed: 22682245
PLoS Biol. 2011 Feb 15;9(2):e1000594
pubmed: 21347245
Cell Cycle. 2011 May 15;10(10):1690-8
pubmed: 21508669
Cold Spring Harb Perspect Biol. 2013 Sep 01;5(9):
pubmed: 23838438
Nature. 2012 Mar 14;483(7390):434-8
pubmed: 22419157
Cell Rep. 2017 Nov 14;21(7):1707-1714
pubmed: 29141206
Nucleic Acids Res. 2019 Feb 28;47(4):1814-1822
pubmed: 30541106
Mol Cell. 2014 Apr 10;54(1):94-106
pubmed: 24631285
Oncotarget. 2014 Oct 15;5(19):9396-409
pubmed: 25238049
J Cell Sci. 2014 Jul 1;127(Pt 13):2983-94
pubmed: 24806966
Microb Cell. 2017 Jan 02;4(1):32-34
pubmed: 28357386
Cell Rep. 2020 May 12;31(6):107635
pubmed: 32402281
Science. 2015 Aug 14;349(6249):742-7
pubmed: 26273056
Nat Commun. 2019 Sep 27;10(1):4410
pubmed: 31562309
Nature. 2013 Jan 10;493(7431):246-9
pubmed: 23178809
Nucleic Acids Res. 2020 Jul 27;48(13):7265-7278
pubmed: 32544229
Nature. 2013 Oct 17;502(7471):393-6
pubmed: 24025768
Nat Commun. 2016 Oct 25;7:13157
pubmed: 27779184
Elife. 2019 Jan 22;8:
pubmed: 30667359
FEBS J. 2020 Jul 7;:
pubmed: 32638513
Nat Struct Mol Biol. 2011 Aug 14;18(9):1015-9
pubmed: 21841787
Mol Cell. 2015 Aug 6;59(3):462-77
pubmed: 26166705
Genome Res. 2014 Feb;24(2):291-9
pubmed: 24389050
Mol Cell. 2010 Aug 13;39(3):346-59
pubmed: 20705238
Commun Biol. 2019 May 8;2:174
pubmed: 31098407
Genes Dev. 2010 Jun 1;24(11):1133-44
pubmed: 20516198
Nat Rev Cancer. 2015 May;15(5):276-89
pubmed: 25907220
EMBO J. 2005 Jun 1;24(11):2011-23
pubmed: 15889146
Nat Rev Mol Cell Biol. 2020 Oct;21(10):633-651
pubmed: 32612242
Nature. 2008 Nov 20;456(7220):357-61
pubmed: 19020614
PLoS Biol. 2014 Sep 09;12(9):e1001946
pubmed: 25203555
J Biol Chem. 2012 Jun 22;287(26):21980-91
pubmed: 22570476
Nature. 2007 Aug 16;448(7155):820-3
pubmed: 17671506
Nat Rev Cancer. 2017 Jul 25;17(8):489-501
pubmed: 28740117
Genes Dev. 2004 Nov 15;18(22):2764-73
pubmed: 15520275
Cancer Res. 2012 Jun 1;72(11):2802-13
pubmed: 22491672
Elife. 2014 Apr 29;3:e02854
pubmed: 24843031
Science. 2014 Jan 3;343(6166):88-91
pubmed: 24310611
Genes Dev. 2011 Oct 1;25(19):2011-24
pubmed: 21979914
Cell. 2005 Jun 3;121(5):689-702
pubmed: 15935756
Nat Rev Mol Cell Biol. 2015 Apr;16(4):207-20
pubmed: 25714681
Hum Mutat. 2019 Aug;40(8):1063-1070
pubmed: 31045292
Mol Cell. 2017 May 4;66(3):398-410.e4
pubmed: 28475874
Nature. 2007 May 3;447(7140):102-5
pubmed: 17410126
Cell. 2011 May 13;145(4):529-42
pubmed: 21565612
J Cell Biol. 2015 Mar 2;208(5):545-62
pubmed: 25733713
Nat Struct Mol Biol. 2016 May;23(5):402-8
pubmed: 27065195
PLoS Genet. 2014 Oct 16;10(10):e1004679
pubmed: 25329304
Elife. 2015 Mar 25;4:e04539
pubmed: 25806683
Mol Cell. 2017 Jan 5;65(1):131-141
pubmed: 27989437
Cell Cycle. 2014;13(9):1392-9
pubmed: 24626187
J Cell Biol. 2015 Mar 2;208(5):563-79
pubmed: 25733714
DNA Repair (Amst). 2018 Nov;71:135-147
pubmed: 30220600
Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):E5765-74
pubmed: 27630194
Genes (Basel). 2019 Mar 19;10(3):
pubmed: 30893921
Nucleic Acids Res. 2020 Jan 10;48(1):16-35
pubmed: 31754720
Nat Commun. 2017 Dec 7;8(1):1982
pubmed: 29215009
Nat Commun. 2018 Nov 16;9(1):4830
pubmed: 30446656
Chromosoma. 2013 Dec;122(6):499-515
pubmed: 24008669
Nat Cell Biol. 2014 Jan;16(1):2-9
pubmed: 24366029
Mol Cell. 2010 Feb 26;37(4):492-502
pubmed: 20188668
Trends Genet. 2018 Jul;34(7):518-531
pubmed: 29735283
Nature. 2013 Oct 17;502(7471):389-92
pubmed: 24025772

Auteurs

Rowin Appanah (R)

Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9RQ, UK.

David Jones (D)

Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9RQ, UK.

Benoît Falquet (B)

Friedrich Miescher Institute for Biomedical Research, 4058, Basel, Switzerland.
Faculty of Natural Sciences, University of Basel, 4056, Basel, Switzerland.

Ulrich Rass (U)

Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9RQ, UK. U.W.Rass@sussex.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH